Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis.
Tetsuya IkawaTakuya MiyagawaYuki FukuiShun MinatsukiHisataka MakiToshiro InabaMasaru HatanoSatoshi ToyamaJun OmatsuKentaro AwajiYuta NorimatsuYusuke WatanabeAyumi YoshizakiShinichi SatoYoshihide AsanoPublished in: International journal of rheumatic diseases (2021)
Serum CCL20 levels may be involved in the development of pulmonary vascular involvement leading to pulmonary arterial hypertension and asymptomatic PBC in SSc patients.
Keyphrases
- systemic sclerosis
- pulmonary arterial hypertension
- pulmonary hypertension
- end stage renal disease
- interstitial lung disease
- pulmonary artery
- ejection fraction
- chronic kidney disease
- newly diagnosed
- liver fibrosis
- liver injury
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- rheumatoid arthritis
- drug induced
- ulcerative colitis